Publicação
Tissue structure developer: jellyfish-based collagen as an innovative wound healing treatment - business model, funding & exit strategies
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | pt_PT |
| dc.contributor.advisor | Arantes-Oliveira, Nuno | |
| dc.contributor.author | Lückenbach, Arthur Carl Ulrich | |
| dc.date.accessioned | 2025-01-27T12:59:27Z | |
| dc.date.available | 2025-01-27T12:59:27Z | |
| dc.date.issued | 2024-06-12 | |
| dc.date.submitted | 2024-05-17 | |
| dc.description.abstract | TSD, a novel biotech venture, aims to revolutionise the wound healing market by utilising jellyfish, a new source of collagen. Its product, the CollaPatchTM, harnesses the benefits of jellyfish collagen across social, environmental, and ecological dimensions, offering a superior alternative to bovine- and porcine-based collagen products for wound healing. This paper introduces the product with its scientific work, analyses the stakeholders and the competitive environment of the product and presents a detailed business model. It then outlines the funding requirements, targeted sources of funding and exit strategies. | pt_PT |
| dc.identifier.tid | 203724496 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10362/177962 | |
| dc.language.iso | eng | pt_PT |
| dc.relation | (UID/ECO/00124/2013 | pt_PT |
| dc.subject | Biotechnology | pt_PT |
| dc.subject | Biomedical innovation | pt_PT |
| dc.subject | Business strategy | pt_PT |
| dc.subject | Intellectual property | pt_PT |
| dc.subject | Pharmaceutical | pt_PT |
| dc.subject | Competitive analysis | pt_PT |
| dc.subject | Funding | pt_PT |
| dc.subject | Ulcers | pt_PT |
| dc.subject | Wound healing | pt_PT |
| dc.subject | Chronical wounds | pt_PT |
| dc.subject | Jellyfish | pt_PT |
| dc.subject | Marine collagen | pt_PT |
| dc.subject | Venture capital | pt_PT |
| dc.subject | Intrapreneurship | pt_PT |
| dc.subject | Entrepreneurship | pt_PT |
| dc.title | Tissue structure developer: jellyfish-based collagen as an innovative wound healing treatment - business model, funding & exit strategies | pt_PT |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | masterThesis | pt_PT |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Master’s degree in Management from the Nova School of Business and Economics | pt_PT |